TNFRSF11B and chronic myelogenous leukemia, BCR-ABL1 positive: OPG levels were also no different in CML treated cells (0.91, 95% CI: 0.63 - 1.19, p = 0.62) compared to OC (1.04,95% CI: 0.85 - 1.22).